Services-Commercial Physical & Biological Research: capital spending and supply chain
SIC 8731 · 10 companies with filed cash-flow statements
Capital spending, 12 months$943M
Operating cash flow$4.0B
Capex / cash flow24%
Capex / revenue3.1%
Top 3 share99%
Analysis
10 companies in Services-Commercial Physical & Biological Research (SIC 8731) spent $943M on capital projects over their latest twelve months, 24% of the $4.0B their operations generated; the three largest spenders — IQV, CRL, MEDP — account for 99%.
Capital spending is 3.1% of the industry's $30.4B of annual revenue.
By the industry's asset mix most of it goes to software (37%); about $150M is imported.
The largest supplier of that spending is manufacturing structures ($159M).
Its largest supplying industries, by the input-output tables: other real estate ($1.5B), management consulting services ($1.2B), imports ($944M).
Charts
Filed cash-flow statements (SEC XBRL).Capital spending × the industry’s asset mix (BEA fixed assets): grade C, an industry average applied to filed figures.BEA fixed assets: investment by asset type → supplying industry. Estimates (grade C).Purchased inputs × the industry’s input mix (BEA Use table), US part: grade C.The companies’ cash-flow statements, latest four quarters or fiscal year: every figure filed (grade A).
Evidence grades: A filed figure · B computed from filed figures · C industry average (BEA input-output and fixed-asset tables) applied to filed figures. Estimates are not the companies’ own records. Not investment advice.